127
Views
0
CrossRef citations to date
0
Altmetric
Review

ClariVein®, mechanochemical endovenous ablation: patient selection and perspective

, , , &
Pages 1-8 | Published online: 02 Sep 2019

References

  • Bootun R, Onida S, Lane TRA, Davies AH. Varicose veins and their management. Surg (United Kingdom). 2016. doi:10.1016/j.mpsur.2016.02.002
  • Lurie F, Creton D, Eklof B, et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS study). J Vasc Surg. 2003;38(2):207–214. doi:10.1016/s0741-5214(03)00228-3
  • Kugler NW, Brown KR. An update on the currently available nonthermal ablative options in the management of superficial venous disease. J Vasc Surg Venous Lymphat Disord. 2017;5(3):422–429. doi:10.1016/j.jvsv.2017.01.014
  • Braithwaite B, Hnatek L, Zierau U, et al. Radiofrequency-induced thermal therapy: results of a European multicentre study of resistive ablation of incompetent truncal varicose veins. Phlebology. 2013. doi:10.1258/phleb.2012.012013
  • Yang L, Wang XP, Su WJ, Zhang Y, Wang Y. Randomized clinical trial of endovenous microwave ablation combined with high ligation versus conventional surgery for varicose veins. Eur J Vasc Endovasc Surg. 2013. doi:10.1016/j.ejvs.2013.07.004
  • Subwongcharoen S, Praditphol N, Chitwiset S. Endovenous microwave ablation of varicose veins: in vitro, live swine model, and clinical study. Surg Laparosc Endosc Percutan Tech. 2009. doi:10.1097/SLE.0b013e3181987549
  • Van Den Bos RR, Milleret R, Neumann M, Nijsten T. Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins. J Vasc Surg. 2011. doi:10.1016/j.jvs.2010.06.171
  • Wallace T, El-Sheikha J, Nandhra S, et al. Long-term outcomes of endovenous laser ablation and conventional surgery for great saphenous varicose veins. Br J Surg. 2018. doi:10.1002/bjs.10961
  • Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the society for vascular surgery and the American venous forum. J Vasc Surg. 2011;53(5SUPPL):2S–48S. doi:10.1016/j.jvs.2011.01.079
  • Belramman A, Bootun R, Lane TRA, Davies AH. Endovenous management of varicose veins. Angiology. 2018:70(5):388–396. 000331971878004. doi:10.1177/0003319718780049
  • Lane T, Bootun R, Dharmarajah B, et al. A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins – final results of the venefit versus clarivein for varicose veins trial. Phlebology. 2017;32(2):89–98. doi:10.1177/0268355516651026
  • Tal MG, Dos Santos SJ, Marano JP, Whiteley MS. Histologic findings after mechanochemical ablation in a caprine model with use of clariVein. J Vasc Surg Venous Lymphat Disord. 2015;3(1):81–85. doi:10.1016/j.jvsv.2014.07.002
  • Elias S, Raines JK. Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology. 2012;27(2):67–72. doi:10.1258/phleb.2011.010100
  • Boersma D, van Haelst STW, van Eekeren RRJP, et al. Macroscopic and histologic analysis of vessel wall reaction after mechanochemical endovenous ablation using the clariVein OC device in an animal model. Eur J Vasc Endovasc Surg. 2017;53(2):290–298. doi:10.1016/j.ejvs.2016.11.024
  • Whiteley MS, Dos Santos SJ, Lee CT, Li JM. Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord. 2017;5(3):370–377. doi:10.1016/j.jvsv.2016.12.009
  • Lam YL, Toonder IM, Wittens CHA. ClariVein® mechano-chemical ablation an interim analysis of a randomized controlled trial dose-finding study. Phlebology. 2016;31(3):170–176. doi:10.1177/0268355515599692
  • Van Eekeren RRJP, Boersma D, Konijn V, JPPM DV, Reijnen MMJP. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg. 2013;57(2):445–450. doi:10.1016/j.jvs.2012.07.049
  • Bootun R, Lane TRA, Dharmarajah B, et al. Intra-procedural pain score in a randomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: the multicentre venefitTM versus ClariVein® for varicose veins trial. Phlebology. 2016;31(1):61–65. doi:10.1177/0268355514551085
  • Moore HM, Lane TR, Franklin IJ, Davies AH. Retrograde mechanochemical ablation of the small saphenous vein for the treatment of a venous ulcer. Vascular. 2014;22(5):375–377. doi:10.1177/1708538113516320
  • Elias S 21. Mechanochemical Ablation (MOCA) of the great saphenous vein: two-year results and recommendations from the initial human trial. J Vasc Surg. 2012;55(6):27S. doi:10.1016/j.jvs.2012.03.280
  • van Eekeren RRJP, Boersma D, Elias S, et al. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study. J Endovasc Ther. 2011;18(3):328–334. doi:10.1583/11-3394.1
  • Boersma D, Van Eekeren RRJP, Werson DAB, Van Der Waal RIF, Reijnen MMJP, De Vries JPPM. Mechanochemical endovenous ablation of small saphenous vein insufficiency using the clariVein®device: one-year results of a prospective series. Eur J Vasc Endovasc Surg. 2013;45(3):299–303. doi:10.1016/j.ejvs.2012.12.004
  • Ramon RJP, van Eekeren D, Boersma S, et al. MD, PhD a A and N, Netherland T. Mechanochemical endovenous ablation for the treatment of great saphenous vein insufficiency. Ann Acad Med Singapore. 2014;33(2):204–208. doi:10.1016/j.jvsv.2014.01.001
  • Van EekerWitte ME, Holewijn S, Van Eekeren RR, De Vries JP, Zeebregts CJ, Reijnen MMPJ. Midterm outcome of mechanochemical endovenous ablation for the treatment of great saphenous vein insufficiency. J Endovasc Ther. 2017;24(1):149–155. doi:10.1177/1526602816674455
  • Belramman A, Bootun R, Tang TY, Lane TRA, Davies AH. Mechanochemical ablation versus cyanoacrylate adhesive for the treatment of varicose veins: study protocol for a randomised controlled trial. Trials. 2018;19(1):1–8. doi:10.1186/s13063-018-2807-0
  • Bishawi M, Bernstein R, Boter M, et al. Mechanochemical ablation in patients with chronic venous disease: a prospective multicenter report. Phlebology. 2014;29(6):397–400. doi:10.1177/0268355513495830
  • Deijen CL, Schreve MA, Bosma J, et al. ClariVein mechanochemical ablation of the great and small saphenous vein: early treatment outcomes of two hospitals. Phlebology. 2016;31(3):192–197. doi:10.1177/0268355515600573
  • Kim PS, Bishawi M, Draughn D, et al. Mechanochemical ablation for symptomatic great saphenous vein reflux: a two-year follow-up. Phlebology. 2017;32(1):43–48. doi:10.1177/0268355515627260
  • Tang TY, Kam JW, Gaunt ME. ClariVein® – early results from a large single-centre series of mechanochemical endovenous ablation for varicose veins. Phlebology. 2017;32(1):6–12. doi:10.1177/0268355516630154
  • Leung C, Carradice D, Mohamed A, Hull IC, Hospitals EY. A Randomized controlled trial comparing endovenous laser ablation vs mechanochemical ablation in the treatment of super fi cial venous incompetence : the LAMA trialJ Vasc Surg. 2017;65(6):35S. doi:10.1016/j.jvs.2017.03.070
  • Khor SN, Lei J, Kam JW, Kum S, Tan YK, Tang TY. ClariVeinTM – one year results of mechano-chemical ablation for varicose veins in a multi-ethnic Asian population from Singapore. Phlebology. 2018;33(10):687–694. doi:10.1177/0268355518771225